Phibro Animal Health (PAHC) Tops Q1 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Phibro Animal Health Corporation Reports Second Quarter Results, Provides Revised Financial Guidance
February 9, 2022 4:25 PM ESTTEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (Nasdaq: PAHC) today announced financial results for its second quarter ended December 31, 2021.
Highlights for the three months ended December 31, 2021 (compared to the three months ended December 31, 2020) Net sales of $233 million, an increase of $27 million, or 13% Net income of $17 million, an increase of $5 million, or 36% Diluted EPS of $0.43, an increase of $0.11 or 34% Adjusted EBITDA of $29 million, an increase of $1 million, or... More


